Publications by authors named "Alexander Teml"

Claim this Profile
G
Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans.
Lucas Actis-Goretta, Tristan P Dew, Antoine Lévèques, Gema Pereira-Caro, Maarit Rein, Alexander Teml

Mol Nutr Food Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
Heimo H Wenzl, Christian Primas, Gottfried Novacek, Alexander Teml, Anna Öfferlbauer-Ernst

Dig Dis Sci· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal absorption, metabolism, and excretion of (-)-epicatechin in healthy humans assessed by using an intestinal perfusion technique.
Lucas Actis-Goretta, Antoine Lévèques, Maarit Rein, Alexander Teml, Christian Schäfer

Am J Clin Nutr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Sieglinde Angelberger, Elke Schaeffeler, Alexander Teml, Wolfgang Petritsch, Olga Shonova

Inflamm Bowel Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Walter Reinisch, Sieglinde Angelberger, Wolfgang Petritsch, Olga Shonova, Milan Lukas, Alexander Teml

Gut· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
Maureen J Koslowski, Irmgard Kübler, Mathias Chamaillard, Elke Schaeffeler, Walter Reinisch, Alexander Teml

PLoS One· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
Sieglinde Angelberger, Walter Reinisch, Clemens Dejaco, Wolfgang Miehsler, Thomas Waldhoer, Alexander Teml

Am J Gastroenterol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.
Alexander Teml, Matthias Schwab, Daan W Hommes, Sven Almer, Milan Lukas

Wien Klin Wochenschr· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics and use of infliximab.
Ulrich Klotz, Alexander Teml, Matthias Schwab

Clin Pharmacokinet· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
Arnulf Ferlitsch, Alexander Teml, Walter Reinisch, Gregor Ulbrich, Fritz Wrba

Am J Gastroenterol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe ulcerative colitis complicated by an arterial thrombus in the brachiocephalic trunk.
Markus Haumer, Alexander Teml, Albert Dirisamer, Harald Vogelsang, Renate Koppensteiner

Inflamm Bowel Dis· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
Alexander Teml, Elke Schaeffeler, Klaus R Herrlinger, Ulrich Klotz, Matthias Schwab

Clin Pharmacokinet· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.
Klaus Fellermann, Daniel E Stange, Elke Schaeffeler, Hartmut Schmalzl, Jan Wehkamp, Alexander Teml

Am J Hum Genet· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.
Alexander Teml, Matthias Schwab, Marieluise Harrer, Wolfgang Miehsler, Elke Schaeffeler

Scand J Gastroenterol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine.
Julia Seiderer, Christoph J Zech, Walter Reinisch, Milan Lukas, Joachim Diebold, Alexander Teml

J Hepatol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Alexander Teml, Verena Kratzer, Barbara Schneider, Herbert Lochs, Gary L Norman

Am J Gastroenterol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.
Diana Bonderman, Alexander Teml, Johannes Jakowitsch, Christopher Adlbrecht, Mariann Gyöngyösi

Blood· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis